GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (STU:8BD) » Definitions » Cyclically Adjusted Book per Share

Boule Diagnostics AB (STU:8BD) Cyclically Adjusted Book per Share : €1.05 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Boule Diagnostics AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Boule Diagnostics AB's adjusted book value per share for the three months ended in Mar. 2025 was €0.406. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.05 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Boule Diagnostics AB's average Cyclically Adjusted Book Growth Rate was -0.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Boule Diagnostics AB was 10.10% per year. The lowest was 8.70% per year. And the median was 8.70% per year.

As of today (2025-05-24), Boule Diagnostics AB's current stock price is €0.698. Boule Diagnostics AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €1.05. Boule Diagnostics AB's Cyclically Adjusted PB Ratio of today is 0.66.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boule Diagnostics AB was 6.63. The lowest was 0.58. And the median was 2.68.


Boule Diagnostics AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Boule Diagnostics AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB Cyclically Adjusted Book per Share Chart

Boule Diagnostics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.89 0.95 0.98 0.98

Boule Diagnostics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 1.01 1.00 0.98 1.05

Competitive Comparison of Boule Diagnostics AB's Cyclically Adjusted Book per Share

For the Medical Devices subindustry, Boule Diagnostics AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's Cyclically Adjusted PB Ratio falls into.


;
;

Boule Diagnostics AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boule Diagnostics AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.406/132.8245*132.8245
=0.406

Current CPI (Mar. 2025) = 132.8245.

Boule Diagnostics AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.735 99.995 0.976
201509 0.752 100.228 0.997
201512 0.766 100.276 1.015
201603 0.780 100.751 1.028
201606 0.815 101.019 1.072
201609 0.877 101.138 1.152
201612 0.890 102.022 1.159
201703 0.934 102.022 1.216
201706 0.848 102.752 1.096
201709 0.957 103.279 1.231
201712 0.961 103.793 1.230
201803 0.999 103.962 1.276
201806 1.029 104.875 1.303
201809 1.045 105.679 1.313
201812 1.068 105.912 1.339
201903 1.092 105.886 1.370
201906 1.042 106.742 1.297
201909 1.137 107.214 1.409
201912 1.158 107.766 1.427
202003 1.184 106.563 1.476
202006 1.035 107.498 1.279
202009 1.096 107.635 1.352
202012 0.965 108.296 1.184
202103 0.995 108.360 1.220
202106 0.946 108.928 1.154
202109 0.983 110.338 1.183
202112 1.050 112.486 1.240
202203 1.051 114.825 1.216
202206 1.076 118.384 1.207
202209 1.136 122.296 1.234
202212 1.083 126.365 1.138
202303 1.073 127.042 1.122
202306 1.061 129.407 1.089
202309 1.055 130.224 1.076
202312 1.094 131.912 1.102
202403 1.133 132.205 1.138
202406 1.132 132.716 1.133
202409 0.578 132.304 0.580
202412 0.440 132.987 0.439
202503 0.406 132.825 0.406

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Boule Diagnostics AB  (STU:8BD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Boule Diagnostics AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.698/1.05
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boule Diagnostics AB was 6.63. The lowest was 0.58. And the median was 2.68.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Boule Diagnostics AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB Business Description

Traded in Other Exchanges
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB Headlines

No Headlines